Teijin Limited Signs Joint R&D Agreement with Garwood Medical Devices
/
DateJan 03 2024
Electrochemical therapeutic technology BioPrax™ addresses the high failure rate of joint implants due to infection BUFFALO, NY, UNITED STATES, January 3, 2024 /EINPresswire.com/ — Garwood... Read More →